<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Kite Announces End of Phase 1 ZUMA-3 Results for KTE-X19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia	</title>
	<atom:link href="https://www.novumpr.nl/2019/06/02/kite-announces-end-of-phase-1-zuma-3-results-for-kte-x19-in-adult-patients-with-relapsed-or-refractory-acute-lymphoblastic-leukemia/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.novumpr.nl/2019/06/02/kite-announces-end-of-phase-1-zuma-3-results-for-kte-x19-in-adult-patients-with-relapsed-or-refractory-acute-lymphoblastic-leukemia/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=kite-announces-end-of-phase-1-zuma-3-results-for-kte-x19-in-adult-patients-with-relapsed-or-refractory-acute-lymphoblastic-leukemia</link>
	<description>NovumPR press releases</description>
	<lastBuildDate>Mon, 03 Jun 2019 06:01:36 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.2</generator>
</channel>
</rss>
